Zobrazeno 1 - 10
of 537
pro vyhledávání: ''
Publikováno v:
Clinical Cardiology
Background Many studies have reported the predictors of atrial fibrillation (AF) recurrence after persistent AF (peAF) ablation. However, the correlation between the atrial defibrillation threshold (DFT) for internal cardioversion (IC) and AF recurre
Autor:
Carlos Volponi Lovatto, Christiano Cunha, Aloyr Gonçalves Simoes Jr., Eduardo Serpa, Dalton Amaral, Fabricio Vassallo, Hermes Carloni, Lucas Luis Meigre
Publikováno v:
Pacing and Clinical Electrophysiology. 44:1185-1192
BACKGROUND Atrial fibrillation (AF) ablation is alternative treatment to medical therapy. Most feared complication is atrioesophageal fistula METHODS: Observational, retrospective analysis of consecutive 355 patients undergoing first AF ablation. Low
Autor:
Jonathan Hyde, Nick Freemantle, Steven J. Podd, Conn Sugihara, William Eysenck, Rick A. Veasey, Michael Lewis, Stephen Furniss, Neil Sulke, Rajdip Dulai
Publikováno v:
Pacing and Clinical Electrophysiology. 44:1176-1184
INTRODUCTION There is limited data using continuous monitoring to assess outcomes of atrial fibrillation (AF) ablation. This study assessed long-term outcomes of AF ablation in patients with implantable cardiac devices. METHODS 207 patients (mean age
Autor:
Yuji Ikari, Mitsutoshi Oguri, Takahiko Kiyooka, Akihiko Takahashi, Sho Torii, Kyong Hee Lee, Yuujirou Ono, Kouhei Asada, Tsuyosi Miyaji, Taichi Adachi
Publikováno v:
Catheterization and Cardiovascular Interventions. 99:314-321
OBJECTIVES The objectives of this study is to confirm reduction of door-to-balloon (D2B) time with single-catheter percutaneous coronary intervention (SC-PCI) method. BACKGROUND Reduction of total ischemic time is important in the emergency treatment
Autor:
Talha Farid, Dhanunjaya Lakkireddy, Philip L. Mar, Brian Olshansky, Andrew Murray, Donita Atkins, Christopher R Angus, Rakesh Gopinathannair, Rahul Dhawan
Publikováno v:
Journal of Cardiovascular Electrophysiology. 32:1085-1092
BACKGROUND Arrhythmia-induced cardiomyopathy (AIC) is characterized by improvement in left ventricular ejection fraction (LVEF) following arrhythmia treatment. Predictors of recovery in LVEF are not well understood. OBJECTIVE We evaluated predictors
Publikováno v:
Journal of Cardiovascular Electrophysiology. 32:856-859
Introduction Patients undergoing evaluation for an inherited arrhythmia syndrome undertake a series of ambulatory investigations including 24-h Holter monitor, exercise treadmill testing (ETT), and others. Patch monitors may simplify the evaluation,
Autor:
Grégoire Rangé, Ariel Nakache, Hakim Benamer, Marie-Pascale Decomis, Pierre Marcollet, Olivier Fichaux, Nicolas Danchin, Gilles Montalescot, Christophe Saint Etienne, Pascal Motreff, Guillaume Cayla, Stephan Chassaing, Etienne Puymirat, René Koning, Philippe Commeau
Publikováno v:
Clinical Cardiology
Clinical Cardiology, Wiley, 2020, ⟨10.1002/clc.23567⟩
Clinical Cardiology, Wiley, 2020, ⟨10.1002/clc.23567⟩
International audience; BackgroundST‐elevation myocardial infarction (STEMI) patients with multivessel disease (MVD) are associated with a worse prognosis. However, few comparisons are available according to coronary status in the era of modern rep
Autor:
Mamas A. Mamas, Samuel F. Hohmann, Alyssa Hartsell Harris, Trevor Simard, Stephanie El-Hajj, Mohamad Alkhouli, Benjamin Hibbert, Fahad Alqahtani
Publikováno v:
Catheterization and Cardiovascular Interventions. 98:176-183
BACKGROUND Sex-based differences in transcatheter aortic valve replacement (TAVR) outcomes have been previously documented. However, whether these differences persist with contemporary third generation transcatheter heart valves (THVs) is unknown. ME
Publikováno v:
Pacing and Clinical Electrophysiology. 44:528-540
Catheter ablation using radiofrequency (RF) energy has been widely used to treat patients with atrial fibrillation (AF). The optimal levels of power and duration to increase the success rate while minimizing complications have not been fully establis
Autor:
Philippe Gabriel Steg, A. Darmon, Roberto Ferrari, Emmanuel Sorbets, Jean-Claude Tardif, Ian Ford, Gregory Ducrocq, Laurent J. Feldman, Kim Fox, Michal Tendera, Adam Jasilek
Publikováno v:
Clinical Cardiology
Background:\ud \ud The COMPASS trial showed a reduction of ischemic events with low-dose rivaroxaban and aspirin in chronic coronary syndromes (CCS) compared with aspirin alone, at the expense of increased bleeding.\ud \ud Hypothesis:\ud \ud The CHA